STEPHANIE BUFIS: Open Payments
NPI 1447808985 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 21 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $261 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $317 |
| Inspire Medical Systems, Inc. | 2 | $171 |
| AstraZeneca Pharmaceuticals LP | 4 | $147 |
| Exact Sciences Corporation | 4 | $65 |
| Lilly USA, LLC | 2 | $50 |
| Dexcom, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $24 |
Products named: Ozempic, INSPIRE, AIRSUPRA, MOUNJARO, Dexcom G6 Transmitter, FARXIGA, Cologuard Collection Kit, Auvelity.
Industry payments across TX — which companies pay providers there.
